AI

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

Black Sesame Technologies showcases robotics innovation at Asia Tech x Singapore

Jim Cornall - June 2, 2025

AI

A new hope for AI development

Jim Cornall - May 15, 2025

AI

Could brain-inspired AI help computers see more like humans?

Jim Cornall - April 28, 2025

AI

Rescale reaps $115m to accelerate AI innovation

Jim Cornall - April 21, 2025

AI

Zhejiang University cultivates tomorrow’s tech leaders

Jim Cornall - April 15, 2025

AI

Yutori launches from stealth to build consumer AI assistants

Jim Cornall - April 8, 2025

AI

Transistors: The ideal building block for AI?

Jim Cornall - March 31, 2025

AI

New AI project aims to prevent cyberattacks on wireless networks

Jim Cornall - March 19, 2025

1 234...7 Page 3 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0